EMBCEmbecta Corp. Common Stock

NAS · US · Healthcare · Medical Instruments & Supplies · embecta.com

5.230USD-3.51%Mkt Cap: 296.33M $P/E: 3.563d ago

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringe…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap296.33M $

Enterprise Value1.60B $

Revenue (TTM)1.02B $

Gross Profit676.80M $

Net Income (TTM)95.40M $

Revenue/Share17.33 USD

Last Price5.230 USD

Fiscal Year EndSep 2025

MR QuarterJun 2026

Employees1.9K

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)3.56

P/E (Forward)3.10

PEG—

EV/EBITDA5.67

EV/Revenue1.57

P/S0.30

P/B-0.51

EPS (TTM)1.48

EPS (Forward)1.76

52W Range

2.77019% of range15.55

52W High15.55 USD

52W Low2.770 USD

Profitability

Gross Margin62.64%

Oper. Margin23.67%

EBITDA Margin27.63%

Profit Margin8.83%

ROE-14.65%

ROA8.75%

Growth

Revenue Growth-8.10%

Earnings Growth-53.70%

Cash Flow & Leverage

Operating CF191.70M $

CapEx (TTM)9.30M $

FCF Margin13.57%

FCF Yield46.64%

Net Debt1.29B $

Net Debt/EBITDA4.57

Balance Sheet

Debt/Equity-2.20

Current Ratio1.68

Quick Ratio0.94

Book Value/Sh-10.8140 USD

Cash/Share3.789 USD

Dividends

Fwd Div Rate0.0400 USD

Trail. Div Rate0.4600 USD

Div. Yield0.74%

5Y Avg Yield—

Payout Ratio31.29%

Ex-Div DateAug 27, 2026

Pay DateSep 15, 2026

Analyst Consensus

Rating3.3 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)4.000 USD

Upside (mean)-23.5%

Target Range3.000 USD – 5.000 USD

$3.000-23.5% to mean$5.000

# Analysts2

Ownership

Shares Out.56.66M

Float54.77M

Insiders2.02%

Institutions92.08%

Short Interest

Short Ratio4.8d

Short % Float14.18%

Short % Out.11.79%

Shares Short6.68M

Short (prev mo.)5.85M

Technical

SMA 503.659 (+43.0%)

SMA 2008.182 (-36.1%)

Beta0.79

S&P 52W Chg18.16%

Avg Vol (30d)1.54M

Avg Vol (10d)2.34M

Technical Indicators

RSI (14)71.2

MACD0.4842

MACD Signal0.3535

MACD Hist.+0.1307

BB Upper5.753 USD

BB Middle4.209 USD

BB Lower2.666 USD

BB Width73.33%

ATR (14)0.3084 USD

Vol Ratio (20d)0.68x